LAVA Therapeutics N.V.
LAVA Therapeutics N.V.（LVTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
lvtx · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年2月3日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Hold
6 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$3.75
+115.5% upside
Low
$1.50
Median: $3.75 · Last Close: $1.74
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$3.75
115.5% upside
High Target
$6
244.8%
Low Target
$1.5
-13.8%
Current Price
$1.74
as of today
Based on analyst price targets, the LVTX stock price prediction for the next 12 months ranges from $1.5 to $6. The consensus LVTX price forecast of $3.75 implies 115.5% upside from the current price of $1.74.
短期股价预测
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LVTX · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-08-05 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2025-08-05 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-05-15 | JMP Securities | Maintains | Market Perform→Market Perform |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-02-27 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-12-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-12 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2024-12-11 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2024-08-21 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-06-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on LAVA Therapeutics N.V. (LVTX) stock. Of the recent 19 rating actions, 0 were upgrades and 4 were downgrades. 6 analysts currently cover LVTX.
分析师推荐趋势
LVTX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$17M
↑ 322.8% YoY
Revenue Next Year
$23M
↑ 38.7% YoY
EPS This Year
$-1.39
EPS Next Year
$-0.54
↓ 61.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast LVTX EPS of $-1.39 for the current fiscal year, based on estimates from 1 analysts. The LVTX revenue forecast is $17M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
LVTX 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LVTX 的共识目标价为 $3.75（+115.5% 上行空间），分析师共识为 Hold。
LAVA Therapeutics N.V. 在 NASDAQ 上市，代码 LVTX。LVTX 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 33% 对应 Hold 共识。
常见问题
LVTX 预测 · 8 个问题根据 6 位华尔街分析师，LVTX 的 12 个月平均目标价为 $3.75，最高 $6.00、最低 $1.50。若有图表，中位目标价可在上方查看。相对当前价 $1.74，隐含约 +115.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.